DCGI asked manufacturers of Ranitidine API & formulations to verify their products and take appropriate measures to ensure patient safety after news of ranitidine contamination came in picture.
source https://www.pharmatutor.org/pharma-news/2019/dcgi-took-measures-on-ranitidine-contamination-to-ensure-patient-safety
No comments:
Post a Comment